Ledger.Open graph →
SEC Form D · filed April 9, 2020

Actym Therapeutics, Inc

Offering
$41.2M
Sold
$14.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BERKELEY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Christopher D. Thanos · Berkeley, CAExec · Director · PromoterKanad D. Das · Berkeley, CADirectorAmit D. Kumar · Berkeley, CADirector · PromoterJames D. Huang · Berkeley, CADirectorKanad D. Das · Berkeley, CADirectorAmit D. Kumar · Berkeley, CADirector · PromoterJames D. Huang · Berkeley, CADirectorChristopher D. Thanos · Berkeley, CAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗